UBS Group’s Monterey Innovation Acquisition Corp. Common Stock MTRY Stock Holding History

UBS Group’s Portfolio MTRY Stock Details MTRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$1.12K	–	10412
2023 Q3	$1.12K	Buy	+100	New	+$1.12K	﹤0.01%	8093
2023 Q1	–	Sell	-740	Closed	-$7.77K	–	10980
2022 Q4	$7.77K	Sell	740 -1,700	-70%	-$17.5K	﹤0.01%	8861
2022 Q3	$25K	Buy	2,440 +1,177	+93%	+$11.9K	﹤0.01%	7122
2022 Q2	$13K	Sell	1,263 -383	-23%	-$3.83K	﹤0.01%	7588
2022 Q1	$16K	Buy	+1,646	New	+$16.3K	﹤0.01%	7777

UBS Group's MTRY Position: Q4 2023 in Review

UBS Group sold out of Monterey Innovation Acquisition Corp. Common Stock (MTRY) in Q4 2023, closing a stake of 100 shares — an estimated $1.12K sold.

UBS Group first reported a position in MTRY in Q1 2022 and held it in 5 quarters. The position peaked at $25K in Q3 2022. 0 funds tracked by Wall St. Rank hold MTRY as of Q4 2023.

UBS Group reported no remaining Monterey Innovation Acquisition Corp. Common Stock position as of Q4 2023 after selling out during the quarter.
UBS Group sold 100 Monterey Innovation Acquisition Corp. Common Stock shares in Q4 2023, an estimated $1.12K.
UBS Group first reported a position in Monterey Innovation Acquisition Corp. Common Stock in Q1 2022 and held it in 5 quarters.
UBS Group's Monterey Innovation Acquisition Corp. Common Stock position peaked at $25K in Q3 2022.
0 funds tracked by Wall St. Rank held Monterey Innovation Acquisition Corp. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.